The Oncology Consortia of Criterium Global CRO are a collaboration of 2 outstanding Cancer Research Consortia that deliver innovative research and unparalleled expertise:
The Academic GI Cancer Consortium (AGICC) and the Academic Myeloma Consortium (AMyC). The Consortia Model utilizes translational science methodologies to streamline cancer research and development. Read more on the Consortia model for progressive research.
Providing expertise and innovative solutions for the rapid design, implementation, management and completion of complex GI cancer trials.
The Academic GI Cancer Consortium is an innovative research model that brings together a world class team of institutions and investigators to design and rapidly complete clinical trials in gastrointestinal (GI) cancers.
“I can’t emphasize enough the value that will be added by having the GI Cancer Consortium involved in a GI trial. What you get are the highest quality institutions working together to complete a study faster and with the best possible data.” — Jordan Berlin, MD, Vanderbilt University
The Academic Myeloma Consortium has brought together an expert team of institutions and investigators to design and rapidly complete clinical trials with the ultimate goal of identifying new drugs to treat this disease.
“AMyC fills a critical need for pharmaceutical sponsors, providing an unparalleled level of strategic, scientific, and operational expertise in a timely manner.” — Brian G.M. Durie, MD,